These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26686501)

  • 1. Therapeutic Dose Monitoring for Linezolid in a Patient with MRSA Pneumonia with Bacteremia in Diabetes Insipidus.
    Nakamura Y; Uchiyama M; Hara S; Mizunuma M; Nakano T; Ishikura H; Hoshino K; Kawano Y; Takata T
    Infect Dis Ther; 2016 Mar; 5(1):81-7. PubMed ID: 26686501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of linezolid compared with glycopeptides in methicillin-resistant Staphylococcus aureus severe pneumonia in piglets.
    Luna CM; Bruno DA; García-Morato J; Mann KC; Risso Patrón J; Sagardía J; Absi R; García Bottino M; Marchetti D; Famiglietti A; Baleztena M; Biancolini C
    Chest; 2009 Jun; 135(6):1564-1571. PubMed ID: 19141525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
    Wunderink RG; Mendelson MH; Somero MS; Fabian TC; May AK; Bhattacharyya H; Leeper KV; Solomkin JS
    Chest; 2008 Dec; 134(6):1200-1207. PubMed ID: 18719064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.
    Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y
    J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model.
    Chen J; Feng G; Song Y; Wardenburg JB; Lin S; Inoshima I; Otto M; Wunderink RG
    PLoS One; 2013; 8(6):e67994. PubMed ID: 23826353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model.
    Kong D; Liu X; Li X; Hu J; Li X; Xiao J; Dai Y; He M; Liu X; Jiang Y; Cui R; Zhang L; Wang J; Li A; Wang F; Zhang Y; Xiao J; Wang W; Zheng C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of pacemaker-lead infection by linezolid-resistant methicillin-resistant Staphylococcus aureus in a hemodialysis patient].
    Kojiro M; Tsuchihashi Y; Ishida M; Furumoto A; Matsuda J; Yanagihara K; Morimoto K; Ariyoshi K
    Kansenshogaku Zasshi; 2012 Nov; 86(6):778-83. PubMed ID: 23367855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and Within-Host Genetic Evolution of Methicillin-Resistant
    Rouard C; Garnier F; Leraut J; Lepainteur M; Rahajamananav L; Languepin J; Ploy MC; Bourgeois-Nicolaos N; Doucet-Populaire F
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of linezolid in the treatment of hospital-acquired pneumonia caused by MRSA: a prospective observational study.
    Watanabe A; Goto H; Soma K; Kikuchi T; Gomi K; Miki H; Maemondo M; Ikeda H; Kuroki J; Wada H; Yokoyama T; Izumi S; Mitsutake K; Ueda Y
    J Infect Chemother; 2012 Apr; 18(2):160-8. PubMed ID: 22041987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of linezolid against Panton-Valentine leukocidin (PVL)-positive meticillin-resistant Staphylococcus aureus (MRSA) in a mouse model of haematogenous pulmonary infection.
    Yanagihara K; Kihara R; Araki N; Morinaga Y; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Tsukamoto K; Kamihira S
    Int J Antimicrob Agents; 2009 Nov; 34(5):477-81. PubMed ID: 19665359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumonia.
    Bhan U; Podsiad AB; Kovach MA; Ballinger MN; Keshamouni V; Standiford TJ
    PLoS One; 2015; 10(1):e0114574. PubMed ID: 25635685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH; Kim HB; Kim HS; Lee MJ; Jung Y; Kim G; Hwang JH; Kim NH; Kim M; Kim CJ; Choe PG; Chung JY; Park WB; Kim ES; Park KU; Kim NJ; Kim EC; Oh MD
    Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated creatine phosphokinase levels associated with linezolid therapy.
    Allison GW; Perla RJ; Belliveau PP; Angelis SM
    Am J Health Syst Pharm; 2009 Jun; 66(12):1097-100. PubMed ID: 19498124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y; Song KH; Cho Je; Kim HS; Kim NH; Kim TS; Choe PG; Chung JY; Park WB; Bang JH; Kim ES; Park KU; Park SW; Kim HB; Kim NJ; Oh MD
    Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
    Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H
    J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Linezolid Exposure and the Typical Clinical Laboratory Safety and Bacterial Clearance in Chinese Pediatric Patients.
    Huo BN; Wu YE; Shu L; Zhang RQ; Xiao JW; Li QB; Zhao W; Jia YT; Song L
    Front Pharmacol; 2022; 13():926711. PubMed ID: 35979237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.